The Venture Codex Logo

The Venture Codex

ASKA Pharmaceutical

5-1 Shibaura 2-chome, Minato-ku, Tokyo, 108-8532, Japan

Overview

Produces and wholesales medical equipment and drugs for humans and animals.

Deals · 12mo

1

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series B

Geographic focus

Japan

Sector focus

Manufacturing
Medical Device
Pharmaceutical

Investment portfolio

2rounds
NAMEDATESIZE
Metagen Therapeutics
Feb 2026Participated
$8 MSeries B
Dioseve
Jul 2024Participated
$7 MOther Equity
Metagen Therapeutics
Feb 2026Participated
$8 MSeries B
Dioseve
Jul 2024Participated
$7 MOther Equity
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

ASKA Pharmaceutical: 2 funding rounds are recorded in the selected participation categories.All available history.
ASKA Pharmaceutical: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B01
Other Equity01

Monthly Deal Activity

ASKA Pharmaceutical: 2 deals are recorded across 28 months.All available history.
ASKA Pharmaceutical: 2 deals are recorded across 28 months. All available history
MonthDeals
Jul '241
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '261
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

ASKA Pharmaceutical: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

ASKA Pharmaceutical: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2
AI & Machine Learning1
Space & Frontier Tech1

Deal Size Distribution

ASKA Pharmaceutical: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

ASKA Pharmaceutical: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M2
$10M-$25M0
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

ASKA Pharmaceutical: Japan has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

ASKA Pharmaceutical: Japan has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
Japan2
ASKA Pharmaceutical: 9 co-investors are shown, with ANRI sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

ASKA Pharmaceutical: 9 co-investors are shown, with ANRI sharing 1 recorded deals. All available history
Co-investorShared deals
ANRI1
Archetype Ventures1
Canon Marketing Japan1
DG Daiwa Ventures1
MEDIPAL HOLDINGS CORPORATION1
Miraidoa (Future Venture Capital)1
Nippon Venture Capital1
QR Investment1
Spiral Capital1

Investment Strategy

ASKA Pharmaceutical: Led accounts for 0% and participating for 100% of round participation.All available history.
ASKA Pharmaceutical: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating2100%
ASKA Pharmaceutical: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
ASKA Pharmaceutical: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Yuto Sasaki

マネージャー